Knudsen Announces Opioid Settlement With Eight Drug Makers

Attorney General Austin Knudsen has announced that Montana will receive $2.5 million from in a settlement with eight opioid drug makers to resolve their roles in the nation’s opioid epidemic. Montana will receive $2.5 million of the total $720 million national settlement. The settlement money will be used for opioid abatement which could include programs like opioid use disorder treatment, providing Narcan to emergency or first responders, and drug treatment courts for defendants with opioid-related substance abuse problems or histories. The eight defendants and the total amount they will pay in funds to address the opioid crisis as part of the deal are: Mylan (now part of Viatris): $284,447,916 paid over nine years Hikma: $95,818,293 paid over one to four years Amneal: $71,751,010 paid over 10 years Apotex: $63,682,369 paid in a single year Indivior: $38,022,450 paid over four years Sun: $30,992,087 paid over one to four years Alvogen: $18,680,162 paid in a single year Zydus: $14,859,220 paid in a single year